VSI Winter 2019 Newsletter
Bibliography and Sources
Back to Newsletter
Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16:208–214. https://www.ncbi.nlm.nih.gov/pubmed/12753387/
Drucker AM, Qureshi AA, Thompson JM, Li T, Cho E. Gluten intake and risk of psoriasis, psoriatic arthritis and atopic dermatitis among US women [published online August 9, 2019]. J Am Acad Dermatol. doi:10.1016/j.jaad.2019.08.007 https://www.ncbi.nlm.nih.gov/pubmed/31404570/
Harris JE. "Speaking of Vitiligo. . ." Update on IL-15 vitiligo treatment. Blog. Posted 2020 January 13.
Hu W, Xu Y, et al. Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study. Clin Drug Investig. 2019 Dec;39(12):1233-1238. https://www.ncbi.nlm.nih.gov/pubmed/31522334
Mu EW, Cohen BE, Orlow SJ. Early-onset childhood vitiligo is associated with a more extensive and progressive course. J Am Acad Dermatol. 2015 Sep;73(3):467-70. Epub 2015 June 26. https://www.ncbi.nlm.nih.gov/pubmed/26118892
Palmer, WJ. Breakthrough vitiligo treatment offers longer-lasting results. Dermatology Times. epub 2019 March 2.